Penumbra, Inc Increase (Decrease) in Accounts Receivable
Penumbra, Inc (PEN) reported Increase (Decrease) in Accounts Receivable of $2.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-30
- Penumbra, Inc increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $8.04M, a 68.09% increase year-over-year.
- Penumbra, Inc increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$5.54M.
- Penumbra, Inc increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $6.82M.
- Penumbra, Inc increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $8.45M.
- Penumbra, Inc increase (decrease) in accounts receivable for fiscal 2025 was $19.51M.
- Penumbra, Inc increase (decrease) in accounts receivable for fiscal 2024 was -$26.60M, a 10098.87% decline from fiscal 2023.
- Penumbra, Inc increase (decrease) in accounts receivable for fiscal 2023 was $266.00K, a 99.62% decline from fiscal 2022.
- Penumbra, Inc increase (decrease) in accounts receivable for fiscal 2022 was $69.86M, a 227.29% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.50M 10-Q · filed 2026-07-30 | $9.32M derived: sum of 3 quarters · filed 2026-07-30 | $17.77M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$5.54M 10-Q · filed 2026-05-06 | $1.28M derived: sum of 2 quarters · filed 2026-05-06 | $9.73M derived: sum of 3 quarters · filed 2026-05-06 | $14.52M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.28M derived: sum of 2 quarters · filed 2026-02-25 | $20.06M derived: sum of 3 quarters · filed 2026-07-30 | $19.51M 10-K · filed 2026-02-25 |
| 2025-09-30 | $8.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.23M derived: sum of 2 quarters · filed 2026-07-30 | $12.69M 10-Q · filed 2025-11-05 | $9.46M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $4.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.24M 10-Q · filed 2026-07-30 | $1.01M derived: sum of 3 quarters · filed 2026-07-30 | -$24.39M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$543.00K 10-Q · filed 2026-05-06 | -$3.77M derived: sum of 2 quarters · filed 2026-05-06 | -$29.17M derived: sum of 3 quarters · filed 2026-05-06 | -$18.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$28.63M derived: sum of 2 quarters · filed 2026-02-25 | -$18.14M derived: sum of 3 quarters · filed 2026-02-25 | -$26.60M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$25.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$14.90M derived: sum of 2 quarters · filed 2025-11-05 | -$23.36M 10-Q · filed 2025-11-05 | -$29.71M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $10.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $2.03M 10-Q · filed 2025-07-29 | -$4.31M derived: sum of 3 quarters · filed 2026-02-25 | -$6.13M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$8.46M 10-Q · filed 2025-04-23 | -$14.80M derived: sum of 2 quarters · filed 2026-02-25 | -$16.61M derived: sum of 3 quarters · filed 2026-02-25 | -$11.73M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$8.15M derived: sum of 2 quarters · filed 2026-02-25 | -$3.27M derived: sum of 3 quarters · filed 2026-02-25 | $266.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $3.07M derived: sum of 2 quarters · filed 2024-10-30 | $6.61M 10-Q · filed 2024-10-30 | $19.11M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $4.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $8.42M 10-Q · filed 2024-07-30 | $20.92M derived: sum of 3 quarters · filed 2025-02-18 | $23.98M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $3.54M 10-Q · filed 2024-05-07 | $16.04M derived: sum of 2 quarters · filed 2025-02-18 | $19.10M derived: sum of 3 quarters · filed 2025-02-18 | $64.69M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $12.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $15.56M derived: sum of 2 quarters · filed 2025-02-18 | $61.15M derived: sum of 3 quarters · filed 2025-02-18 | $69.86M 10-K · filed 2025-02-18 |
| 2022-09-30 | $3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $48.65M derived: sum of 2 quarters · filed 2023-11-02 | $57.36M 10-Q · filed 2023-11-02 | $71.74M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $45.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $54.30M 10-Q · filed 2023-08-01 | $68.68M derived: sum of 3 quarters · filed 2024-02-22 | $52.74M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $8.71M 10-Q · filed 2023-05-02 | $23.09M derived: sum of 2 quarters · filed 2024-02-22 | $7.16M derived: sum of 3 quarters · filed 2024-02-22 | $17.11M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $14.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$1.55M derived: sum of 2 quarters · filed 2024-02-22 | $8.40M derived: sum of 3 quarters · filed 2024-02-22 | $21.34M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$15.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$5.98M derived: sum of 2 quarters · filed 2022-11-03 | $6.96M 10-Q · filed 2022-11-03 | $7.82M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $9.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $22.90M 10-Q · filed 2022-08-05 | $23.75M derived: sum of 3 quarters · filed 2023-02-23 | $37.95M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $12.94M 10-Q · filed 2022-05-03 | $13.79M derived: sum of 2 quarters · filed 2023-02-23 | $28.00M derived: sum of 3 quarters · filed 2023-02-23 | $21.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $15.05M derived: sum of 2 quarters · filed 2023-02-23 | $8.06M derived: sum of 3 quarters · filed 2023-02-23 | $8.29M 10-K · filed 2023-02-23 |
| 2020-09-30 | $14.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $7.21M derived: sum of 2 quarters · filed 2021-11-03 | $7.44M 10-Q · filed 2021-11-03 | $10.95M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$6.76M 10-Q · filed 2021-08-09 | -$3.25M derived: sum of 3 quarters · filed 2022-02-22 | $720.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $238.00K 10-Q · filed 2021-05-04 | $3.75M derived: sum of 2 quarters · filed 2022-02-22 | $7.71M derived: sum of 3 quarters · filed 2022-02-22 | $11.89M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $7.48M derived: sum of 2 quarters · filed 2022-02-22 | $11.66M derived: sum of 3 quarters · filed 2022-02-22 | $25.03M 10-K · filed 2022-02-22 |
| 2019-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $8.15M derived: sum of 2 quarters · filed 2020-11-02 | $21.52M 10-Q · filed 2020-11-02 | $24.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $17.55M 10-Q · filed 2020-08-03 | $20.03M derived: sum of 3 quarters · filed 2021-02-23 | $27.02M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $13.37M 10-Q · filed 2020-05-07 | $15.85M derived: sum of 2 quarters · filed 2021-02-23 | $22.84M derived: sum of 3 quarters · filed 2021-02-23 | $33.03M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $9.46M derived: sum of 2 quarters · filed 2021-02-23 | $19.65M derived: sum of 3 quarters · filed 2021-02-23 | $25.76M 10-K · filed 2021-02-23 |
| 2018-09-30 | $6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $17.18M derived: sum of 2 quarters · filed 2019-11-07 | $23.28M 10-Q · filed 2019-11-07 | $33.11M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $10.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $16.30M 10-Q · filed 2019-08-06 | $26.12M derived: sum of 3 quarters · filed 2020-02-26 | $20.86M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $6.11M 10-Q · filed 2019-05-07 | $15.93M derived: sum of 2 quarters · filed 2020-02-26 | $10.68M derived: sum of 3 quarters · filed 2020-02-26 | $13.35M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $9.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $4.57M derived: sum of 2 quarters · filed 2020-02-26 | $7.24M derived: sum of 3 quarters · filed 2020-02-26 | $9.12M 10-K · filed 2020-02-26 |
| 2017-09-30 | -$5.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$2.58M derived: sum of 2 quarters · filed 2018-11-05 | -$704.00K 10-Q · filed 2018-11-05 | $6.77M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $4.55M 10-Q · filed 2018-08-07 | $12.02M derived: sum of 3 quarters · filed 2019-02-26 | $14.05M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $1.88M 10-Q · filed 2018-05-08 | $9.35M derived: sum of 2 quarters · filed 2019-02-26 | $11.38M derived: sum of 3 quarters · filed 2019-02-26 | $15.10M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $9.50M derived: sum of 2 quarters · filed 2019-02-26 | $13.22M derived: sum of 3 quarters · filed 2019-02-26 | $14.56M 10-K · filed 2019-02-26 |
| 2016-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.75M derived: sum of 2 quarters · filed 2017-11-07 | $7.09M 10-Q · filed 2017-11-07 | $10.77M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $5.06M 10-Q · filed 2017-08-08 | $8.74M derived: sum of 3 quarters · filed 2018-02-27 | $11.18M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.34M 10-Q · filed 2017-05-09 | $5.02M derived: sum of 2 quarters · filed 2018-02-27 | $7.47M derived: sum of 3 quarters · filed 2018-02-27 | $9.47M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $6.12M derived: sum of 2 quarters · filed 2018-02-27 | $8.13M derived: sum of 3 quarters · filed 2018-02-27 | $11.06M 10-K · filed 2018-02-27 |
| 2015-09-30 | $2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.45M derived: sum of 2 quarters · filed 2016-11-03 | $7.38M 10-Q · filed 2016-11-03 | $9.84M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.94M 10-Q · filed 2016-08-09 | $7.39M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2015-03-31 | $2.93M 10-Q · filed 2016-05-09 | $5.39M derived: sum of 2 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $7.43M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $4.97M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $1.55M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |